PL362704A1 - Zmodyfikowany rzęskowy czynnik neurotropowy (CNTF) o obniżonej immunogeniczności - Google Patents

Zmodyfikowany rzęskowy czynnik neurotropowy (CNTF) o obniżonej immunogeniczności

Info

Publication number: PL362704A1
Authority: PL; Poland
Prior art keywords: cntf; neurotrophic factor; reduced immunogenicity; ciliary neurotrophic; modified ciliary
Prior art date: 2001-03-02

Application number

PL02362704A

Other languages

English (en)

Inventor

Francis J. Carr

Graham Carter

Original Assignee

Merck Patent Gmbh

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2001-03-02

Filing date

2002-02-27

Publication date

2004-11-02

2002-02-27 Application filed by Merck Patent Gmbh filed Critical Merck Patent Gmbh

2004-11-02 Publication of PL362704A1 publication Critical patent/PL362704A1/pl

Links

101150030072 CNTF gene Proteins 0.000 title 1
108010005939 Ciliary Neurotrophic Factor Proteins 0.000 title 1
102100031614 Ciliary neurotrophic factor Human genes 0.000 title 1
230000005847 immunogenicity Effects 0.000 title 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/18—Growth factors; Growth regulators
- A61K38/185—Nerve growth factor [NGF]; Brain derived neurotrophic factor [BDNF]; Ciliary neurotrophic factor [CNTF]; Glial derived neurotrophic factor [GDNF]; Neurotrophins, e.g. NT-3
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/475—Growth factors; Growth regulators
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/53—DNA (RNA) vaccination

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Medicinal Chemistry (AREA)
General Health & Medical Sciences (AREA)
Gastroenterology & Hepatology (AREA)
Engineering & Computer Science (AREA)
Zoology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Molecular Biology (AREA)
Pharmacology & Pharmacy (AREA)
Genetics & Genomics (AREA)
Biophysics (AREA)
Toxicology (AREA)
Biochemistry (AREA)
Bioinformatics & Cheminformatics (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Animal Behavior & Ethology (AREA)
Biomedical Technology (AREA)
Neurology (AREA)
Epidemiology (AREA)
Immunology (AREA)
Psychology (AREA)
Neurosurgery (AREA)
Obesity (AREA)
Child & Adolescent Psychology (AREA)
Diabetes (AREA)
Hematology (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Peptides Or Proteins (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Preparation Of Compounds By Using Micro-Organisms (AREA)

PL02362704A 2001-03-02 2002-02-27 Zmodyfikowany rzęskowy czynnik neurotropowy (CNTF) o obniżonej immunogeniczności PL362704A1 (pl)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
EP01105089		2001-03-02
PCT/EP2002/002084 WO2002070698A2 (en)	2001-03-02	2002-02-27	Modified ciliary neurotrophic factor (cntf) with reduced immunogenicity

Publications (1)

Publication Number	Publication Date
PL362704A1 true PL362704A1 (pl)	2004-11-02

Family

ID=8176647

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
PL02362704A PL362704A1 (pl)	2001-03-02	2002-02-27	Zmodyfikowany rzęskowy czynnik neurotropowy (CNTF) o obniżonej immunogeniczności

Country Status (13)

Country	Link
US (1)	US20040087503A1 (pl)
EP (1)	EP1379655A2 (pl)
JP (1)	JP2004529629A (pl)
KR (1)	KR20030081480A (pl)
CN (1)	CN1494593A (pl)
BR (1)	BR0207705A (pl)
CA (1)	CA2439682A1 (pl)
HU (1)	HUP0303310A2 (pl)
MX (1)	MXPA03007839A (pl)
PL (1)	PL362704A1 (pl)
RU (1)	RU2003129069A (pl)
WO (1)	WO2002070698A2 (pl)
ZA (1)	ZA200307678B (pl)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US20050064555A1 (en) *	2003-07-09	2005-03-24	Xencor, Inc.	Ciliary neurotrophic factor variants
US20050069987A1 (en) *	2003-09-30	2005-03-31	Daly Thomas J.	Modified ciliary neurotrophic factor polypeptides with reduced antigenicity
EP2009103A1 (en) *	2007-03-16	2008-12-31	Ebewe Pharma Ges.m.b.H. Nfg. KG	Neurotrophic peptides
US8592374B2 (en)	2007-03-16	2013-11-26	Research Foundation For Mental Hygiene, Inc.	Neurotrophic peptides
WO2009014835A2 (en) *	2007-06-21	2009-01-29	Angelica Therapeutics, Inc.	Modified toxins
EP2268297A4 (en) *	2008-02-29	2011-11-16	Angelica Therapeutics Inc	MODIFIED TOXINS
DE102011104822A1 (de)	2011-06-18	2012-12-20	Christian-Albrechts-Universität Zu Kiel	Ciliary-Neutrophic-Factor-Varianten
HK1220376A1 (zh)	2013-03-15	2017-05-05	Angelica Therapeutics, Inc.	修饰的毒素
WO2016077823A2 (en) *	2014-11-14	2016-05-19	D. E. Shaw Research, Llc	Suppressing interaction between bonded particles
CA3045925A1 (en) *	2016-12-06	2018-06-14	The Board Of Trustees Of The Leland Stanford Junior University	Ciliary neurotrophic factor receptor ligand-binding agents and methods of using the same

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5593857A (en) *	1991-08-23	1997-01-14	Scios Inc.	Production of homogeneous truncated CNTF
CA2123234A1 (en) *	1991-11-11	1993-05-27	Lanfranco Callegaro	Synthesis and purification of truncated and mutein forms of human ciliary neuronotrophic factor
US5939534A (en) *	1993-12-29	1999-08-17	Sumitomo Pharmaceuticals Company, Limited	Factors mutated in the D1 cap region
IT1288388B1 (it) *	1996-11-19	1998-09-22	Angeletti P Ist Richerche Bio	Uso di sostanze che attivano il recettore del cntf ( fattore neurotrofico ciliare) per la preparazione di farmaci per la terapia
EP1200589A1 (en) *	1999-08-13	2002-05-02	Regeneron Pharmaceuticals, Inc.	Modified ciliary neurotrophic factor, method of making and methods of use thereof

2002
- 2002-02-27 CA CA002439682A patent/CA2439682A1/en not_active Abandoned
- 2002-02-27 PL PL02362704A patent/PL362704A1/pl unknown
- 2002-02-27 CN CNA028058666A patent/CN1494593A/zh active Pending
- 2002-02-27 WO PCT/EP2002/002084 patent/WO2002070698A2/en not_active Ceased
- 2002-02-27 BR BR0207705-1A patent/BR0207705A/pt not_active IP Right Cessation
- 2002-02-27 EP EP02724185A patent/EP1379655A2/en not_active Withdrawn
- 2002-02-27 JP JP2002570723A patent/JP2004529629A/ja not_active Withdrawn
- 2002-02-27 HU HU0303310A patent/HUP0303310A2/hu unknown
- 2002-02-27 KR KR10-2003-7011480A patent/KR20030081480A/ko not_active Withdrawn
- 2002-02-27 RU RU2003129069/13A patent/RU2003129069A/ru not_active Application Discontinuation
- 2002-02-27 MX MXPA03007839A patent/MXPA03007839A/es unknown
- 2002-02-27 US US10/469,837 patent/US20040087503A1/en not_active Abandoned
2003
- 2003-10-01 ZA ZA200307678A patent/ZA200307678B/en unknown

Also Published As

Publication number	Publication date
BR0207705A (pt)	2004-03-23
HUP0303310A2 (hu)	2003-12-29
WO2002070698A3 (en)	2003-11-20
JP2004529629A (ja)	2004-09-30
EP1379655A2 (en)	2004-01-14
US20040087503A1 (en)	2004-05-06
MXPA03007839A (es)	2003-12-08
CA2439682A1 (en)	2002-09-12
KR20030081480A (ko)	2003-10-17
RU2003129069A (ru)	2005-04-20
WO2002070698A2 (en)	2002-09-12
CN1494593A (zh)	2004-05-05
ZA200307678B (en)	2004-08-31

Legal Events

Date	Code	Title	Description
2007-10-31	DISC	Decisions on discontinuance of the proceedings (taken after the publication of the particulars of the applications)

Publication	Publication Date	Title
MXPA03007005A (es)	2003-11-18	Factor neutrofico derivado del cerebro (bdnf) humano modificado con unmunogenicidad reducida.
HUP0303534A3 (en)	2005-12-28	Modified interferon beta with reduced immunogenicity
MXPA03007839A (es)	2003-12-08	Factor neurotrofico ciliar modificaco con inmunogenicidad reducida.
HUP0400703A3 (en)	2006-06-28	Modified erythropoietin (epo) with reduced immunogenicity
PL362375A1 (pl)	2004-10-18	Zmodyfikowana leptyna o obniżonej immunogeniczności
PL352625A1 (en)	2002-09-09	Prop
MXPA03007838A (es)	2003-12-08	Interferon alfa modificado con inmunogenicidad reducida.
GB0228460D0 (en)	2003-01-08	Multi-power heaters
HUP0303430A3 (en)	2005-11-28	Modified protamine with reduced immunogenicity
GB2371143B (en)	2005-01-12	Reflectron
AU2002318513A1 (en)	2003-01-21	Novel neurotrophic factors
GB2383750B (en)	2004-04-14	Sunshade with lamps
HUP0303523A3 (en)	2005-12-28	Modified insulin with reduced immunogenicity
GB0114619D0 (en)	2001-08-08	Heated bedstead
JP2003022078A5 (pl)	2008-08-14
GB0116498D0 (en)	2001-08-29	Patio eater
GB0100499D0 (en)	2001-02-21	Envelope
GB2372248B (en)	2003-12-24	Kiln furniture
GB0112260D0 (en)	2001-07-11	Lifting mechanism
GB0101256D0 (en)	2001-02-28	Press controls
GB2412555B (en)	2006-01-11	Multi-power heaters
TW507571U (en)	2002-10-21	Elevating mechanism
TW476262U (en)	2002-02-11	Improved chair structure
TW500212U (en)	2002-08-21	Improved desk lamp elevating structure
TW557993U (en)	2003-10-11	Convection type lamp structure